Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Nuclear Imaging Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Research Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Nuclear Imaging Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Positron Emission Tomography
      • 1.3.3 Single-photon Emission Computed Tomography
      • 1.3.4 Planar Scintigraphy Systems
    • 1.4 Market Segment by Application
      • 1.4.1 Global Nuclear Imaging Market Share by Application (2019-2025)
      • 1.4.2 Oncology
      • 1.4.3 Cardiology
      • 1.4.4 Neurology
      • 1.4.5 Others
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Production and Capacity Analysis
      • 2.1.1 Global Nuclear Imaging Production Value 2014-2025
      • 2.1.2 Global Nuclear Imaging Production 2014-2025
      • 2.1.3 Global Nuclear Imaging Capacity 2014-2025
      • 2.1.4 Global Nuclear Imaging Marketing Pricing and Trends
    • 2.2 Key Producers Growth Rate (CAGR) 2019-2025
      • 2.2.1 Global Nuclear Imaging Market Size CAGR of Key Regions
      • 2.2.2 Global Nuclear Imaging Market Share of Key Regions
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Capacity and Production by Manufacturers
      • 3.1.1 Global Nuclear Imaging Capacity by Manufacturers
      • 3.1.2 Global Nuclear Imaging Production by Manufacturers
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Nuclear Imaging Revenue by Manufacturers (2014-2019)
      • 3.2.2 Nuclear Imaging Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Nuclear Imaging Market Concentration Ratio (CR5 and HHI)
    • 3.3 Nuclear Imaging Price by Manufacturers
    • 3.4 Key Manufacturers Nuclear Imaging Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Nuclear Imaging Market
    • 3.6 Key Manufacturers Nuclear Imaging Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Production and Production Value for Each Type
      • 4.1.1 Positron Emission Tomography Production and Production Value (2014-2019)
      • 4.1.2 Single-photon Emission Computed Tomography Production and Production Value (2014-2019)
      • 4.1.3 Planar Scintigraphy Systems Production and Production Value (2014-2019)
    • 4.2 Global Nuclear Imaging Production Market Share by Type
    • 4.3 Global Nuclear Imaging Production Value Market Share by Type
    • 4.4 Nuclear Imaging Ex-factory Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Nuclear Imaging Consumption by Application

    6 Production by Regions

    • 6.1 Global Nuclear Imaging Production (History Data) by Regions 2014-2019
    • 6.2 Global Nuclear Imaging Production Value (History Data) by Regions
    • 6.3 United States
      • 6.3.1 United States Nuclear Imaging Production Growth Rate 2014-2019
      • 6.3.2 United States Nuclear Imaging Production Value Growth Rate 2014-2019
      • 6.3.3 Key Players in United States
      • 6.3.4 United States Nuclear Imaging Import & Export
    • 6.4 European Union
      • 6.4.1 European Union Nuclear Imaging Production Growth Rate 2014-2019
      • 6.4.2 European Union Nuclear Imaging Production Value Growth Rate 2014-2019
      • 6.4.3 Key Players in European Union
      • 6.4.4 European Union Nuclear Imaging Import & Export
    • 6.5 China
      • 6.5.1 China Nuclear Imaging Production Growth Rate 2014-2019
      • 6.5.2 China Nuclear Imaging Production Value Growth Rate 2014-2019
      • 6.5.3 Key Players in China
      • 6.5.4 China Nuclear Imaging Import & Export
    • 6.6 Rest of World
      • 6.6.1 Japan
      • 6.6.2 Korea
      • 6.6.3 India
      • 6.6.4 Southeast Asia

    7 Nuclear Imaging Consumption by Regions

    • 7.1 Global Nuclear Imaging Consumption (History Data) by Regions
    • 7.2 United States
      • 7.2.1 United States Nuclear Imaging Consumption by Type
      • 7.2.2 United States Nuclear Imaging Consumption by Application
    • 7.3 European Union
      • 7.3.1 European Union Nuclear Imaging Consumption by Type
      • 7.3.2 European Union Nuclear Imaging Consumption by Application
    • 7.4 China
      • 7.4.1 China Nuclear Imaging Consumption by Type
      • 7.4.2 China Nuclear Imaging Consumption by Application
    • 7.5 Rest of World
      • 7.5.1 Rest of World Nuclear Imaging Consumption by Type
      • 7.5.2 Rest of World Nuclear Imaging Consumption by Application
      • 7.5.1 Japan
      • 7.5.2 Korea
      • 7.5.3 India
      • 7.5.4 Southeast Asia

    8 Company Profiles

    • 8.1 GE
      • 8.1.1 GE Company Details
      • 8.1.2 Company Description and Business Overview
      • 8.1.3 Production and Revenue of Nuclear Imaging
      • 8.1.4 Nuclear Imaging Product Introduction
      • 8.1.5 GE Recent Development
    • 8.2 Siemens Healthcare
      • 8.2.1 Siemens Healthcare Company Details
      • 8.2.2 Company Description and Business Overview
      • 8.2.3 Production and Revenue of Nuclear Imaging
      • 8.2.4 Nuclear Imaging Product Introduction
      • 8.2.5 Siemens Healthcare Recent Development
    • 8.3 Philips Healthcare
      • 8.3.1 Philips Healthcare Company Details
      • 8.3.2 Company Description and Business Overview
      • 8.3.3 Production and Revenue of Nuclear Imaging
      • 8.3.4 Nuclear Imaging Product Introduction
      • 8.3.5 Philips Healthcare Recent Development
    • 8.4 Toshiba Medical Systems Corporation
      • 8.4.1 Toshiba Medical Systems Corporation Company Details
      • 8.4.2 Company Description and Business Overview
      • 8.4.3 Production and Revenue of Nuclear Imaging
      • 8.4.4 Nuclear Imaging Product Introduction
      • 8.4.5 Toshiba Medical Systems Corporation Recent Development
    • 8.5 Hitachi Medical
      • 8.5.1 Hitachi Medical Company Details
      • 8.5.2 Company Description and Business Overview
      • 8.5.3 Production and Revenue of Nuclear Imaging
      • 8.5.4 Nuclear Imaging Product Introduction
      • 8.5.5 Hitachi Medical Recent Development
    • 8.6 Digirad
      • 8.6.1 Digirad Company Details
      • 8.6.2 Company Description and Business Overview
      • 8.6.3 Production and Revenue of Nuclear Imaging
      • 8.6.4 Nuclear Imaging Product Introduction
      • 8.6.5 Digirad Recent Development
    • 8.7 DDD-Diagnostics
      • 8.7.1 DDD-Diagnostics Company Details
      • 8.7.2 Company Description and Business Overview
      • 8.7.3 Production and Revenue of Nuclear Imaging
      • 8.7.4 Nuclear Imaging Product Introduction
      • 8.7.5 DDD-Diagnostics Recent Development
    • 8.8 Neusoft Medical Systems
      • 8.8.1 Neusoft Medical Systems Company Details
      • 8.8.2 Company Description and Business Overview
      • 8.8.3 Production and Revenue of Nuclear Imaging
      • 8.8.4 Nuclear Imaging Product Introduction
      • 8.8.5 Neusoft Medical Systems Recent Development
    • 8.9 Mediso
      • 8.9.1 Mediso Company Details
      • 8.9.2 Company Description and Business Overview
      • 8.9.3 Production and Revenue of Nuclear Imaging
      • 8.9.4 Nuclear Imaging Product Introduction
      • 8.9.5 Mediso Recent Development
    • 8.10 SurgicEye
      • 8.10.1 SurgicEye Company Details
      • 8.10.2 Company Description and Business Overview
      • 8.10.3 Production and Revenue of Nuclear Imaging
      • 8.10.4 Nuclear Imaging Product Introduction
      • 8.10.5 SurgicEye Recent Development
    • 8.11 CMR Naviscan

    9 Market Forecast

    • 9.1 Global Market Size Forecast
      • 9.1.1 Global Nuclear Imaging Capacity, Production Forecast 2019-2025
      • 9.1.2 Global Nuclear Imaging Production Value Forecast 2019-2025
    • 9.2 Market Forecast by Regions
      • 9.2.1 Global Nuclear Imaging Production and Value Forecast by Regions 2019-2025
      • 9.2.2 Global Nuclear Imaging Consumption Forecast by Regions 2019-2025
    • 9.3 United States
      • 9.3.1 Production and Value Forecast in United States
      • 9.3.2 Consumption Forecast in United States
    • 9.4 European Union
      • 9.4.1 Production and Value Forecast in European Union
      • 9.4.2 Consumption Forecast in European Union
    • 9.5 China
      • 9.5.1 Production and Value Forecast in China
      • 9.5.2 Consumption Forecast in China
    • 9.6 Rest of World
      • 9.6.1 Japan
      • 9.6.2 Korea
      • 9.6.3 India
      • 9.6.4 Southeast Asia
    • 9.7 Forecast by Type
      • 9.7.1 Global Nuclear Imaging Production Forecast by Type
      • 9.7.2 Global Nuclear Imaging Production Value Forecast by Type
    • 9.8 Consumption Forecast by Application

    10 Value Chain and Sales Channels Analysis

    • 10.1 Value Chain Analysis
    • 10.2 Sales Channels Analysis
      • 10.2.1 Nuclear Imaging Sales Channels
      • 10.2.2 Nuclear Imaging Distributors
    • 10.3 Nuclear Imaging Customers

    11 Opportunities & Challenges, Threat and Affecting Factors

    • 11.1 Market Opportunities
    • 11.2 Market Challenges
    • 11.3 Porter's Five Forces Analysis

    12 Key Findings

      13 Appendix

      • 13.1 Research Methodology
        • 13.1.1 Methodology/Research Approach
          • 13.1.1.1 Research Programs/Design
          • 13.1.1.2 Market Size Estimation
          • 13.1.1.3 Market Breakdown and Data Triangulation
        • 13.1.2 Data Source
          • 13.1.2.1 Secondary Sources
          • 13.1.2.2 Primary Sources
      • 13.2 Author Details

      Molecular imaging, also called nuclear imaging, includes positron emission computed tomography (PET) and single photon emission computed tomography (SPECT) imaging. This section includes radiopharmaceuticals and tracers, PET-CT, SPECT-CT, and PET-MRI.
      Nuclear imaging is used in the diagnosis and treatment of various diseases such as heart disease, cancer, and brain disorders by taking a small amount of radioactive particle and then determining the response with external detectors such as gamma cameras. These devices help in determining the severity and progression of the disease so that effective medication program can be developed.
      In 2019, the market size of Nuclear Imaging is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Nuclear Imaging.

      This report studies the global market size of Nuclear Imaging, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Nuclear Imaging production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      GE
      Siemens Healthcare
      Philips Healthcare
      Toshiba Medical Systems Corporation
      Hitachi Medical
      Digirad
      DDD-Diagnostics
      Neusoft Medical Systems
      Mediso
      SurgicEye
      CMR Naviscan

      Market Segment by Product Type
      Positron Emission Tomography
      Single-photon Emission Computed Tomography
      Planar Scintigraphy Systems

      Market Segment by Application
      Oncology
      Cardiology
      Neurology
      Others

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Nuclear Imaging status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Nuclear Imaging manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Nuclear Imaging are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now